Mic***PhD

Corporate Development

学歴

Massachusetts Institute of Technology

Massachusetts Institute of Technology (2005 - 2007)

  • Degree: Master of Business Administration - MBA
  • Field of Study: Unknown Field
  • Description:

Massachusetts Institute of Technology - Sloan School of Management (2005 - 2007)

  • Degree: MBA
  • Field of Study: Entrepreneurship and Technology Strategy
  • Description: • Teaching Assistant - New Enterprises (Prof. Noubar Afeyan) • Life Science Panel Lead - MIT Venture Capital Conference

UAB School of Medicine (2002 - 2005)

  • Degree: PhD
  • Field of Study: Cell Biology
  • Description: • Research focus: Understanding the role of TGF-beta signaling in the development of the axial skeleton. • Invited speaker at the Federation of American Societies for Experimental Biology, Transforming Growth Factor-beta Conference, July 2003 • Authored publications in the Journal of Biological Chemistry, European Journal of Biochemistry and Developmental Biology

スキル:

Rare Diseases, Private Equity, Non-Governmental Organizations (NGOs), Public Health

職務経験:

Corporate Development at Maravai LifeSciences

  • Location: San Francisco Bay Area
  • Duration: 2021-03 to Present
  • Description: Michael leads the corporate development function at Maravai, covering M&A, strategic partnerships, and investments.

Corporate Business Development at Illumina

  • Location: San Francisco Bay Area
  • Duration: 2018-05 to 2021-03
  • Description: Corporate Business Development leader of inorganic strategy and partnerships in emerging clinical applications for genomics driven drug discovery, clinical development, and molecular diagnostics.

Global Health Leader at Thermo Fisher Scientific

  • Location: San Francisco Bay Area
  • Duration: 2016-01 to 2018-05
  • Description: GM of Global Public Health business vertical within the Genetic Sciences Division of Thermo Fisher Scientific. Full matrix ownership of strategy, product development, R&D, marketing, and commercial execution. Corporate leader of genetic analysis initiatives for (1) National Public Health Surveillance for infectious and genetic diseases, (2) Global pandemic response, and (3) Strategic relationship owner for global NGO partnerships.

Strategy & Corporate Development at Thermo Fisher Scientific

  • Location: San Francisco Bay Area
  • Duration: 2013-03 to 2016-01
  • Description: • Genomic Platforms Strategy Leader (NGS, qPCR, CE) • Corporate Strategy Leader, Life Technologies (acquired by Thermo Fisher Scientific, 2014) Corporate and Divisional Strategy Leader, responsible for the development of annual strategic plans, advisory support for M&A and BD deal teams, early engagement with strategic partners, and management of consulting services.

Corporate Development at Novartis, Molecular Diagnostics

  • Location: Greater San Diego Area
  • Duration: 2012-01 to 2012-12
  • Description:
AI履歴書分析

候補者インテリジェンスレポート

米国の採用ディレクターの視点からAI分析 — キャリアの継続性、成長軌道、および役職適合性を評価します。

キャリアの継続性とリスク評価

Employment GapLow

No significant employment gaps are evident. A minor gap of a few weeks between 2012-12 and 2013-03 is common in transitions and does not indicate disruption.

Industry ConsistencyLow

All roles are within life sciences, biotech, and molecular diagnostics, demonstrating a consistent industry focus.

Tenure StabilityMedium

Past short tenure at Novartis (12 months) introduces some instability signal, but subsequent roles show multi-year durations with increasing scope, mitigating overall risk.

Education-Career MatchLow

Educational background (PhD in life sciences, MIT Sloan MBA, and related chemistry/physiology degrees) directly supports senior corporate development roles in biotech and pharma.

キャリア成長カーブ

Corporate Development Entry
Novartis, Molecular Diagnostics
2012-01 to 2012-12
Strategy & Corporate Development ↑ 昇進
Thermo Fisher Scientific
2013-03 to 2016-01
Global Health Leader ↑ 昇進
Thermo Fisher Scientific
2016-01 to 2018-05
Corporate Business Development ↑ 昇進
Illumina
2018-05 to 2021-03
Corporate Development ↑ 昇進
Maravai LifeSciences
2021-03 to Present
評価:Michael demonstrates a clear, upward trajectory in corporate development and strategy within leading life sciences organizations. The progression to higher strategic scope and P&L/vertical leadership suggests readiness for senior executive roles such as Chief Corporate Development Officer or Head of Corporate Development at a top-tier biopharma/genomics company.

最適な役職(トップ5)

1

Chief Corporate Development Officer95% 適合

Extensive leadership across M&A, partnerships, and investments in top life sciences firms, with current C-level-like responsibility at Maravai. MBA plus PhD strongly supports strategic, financial, and operational rigor required at the C-suite level.

2

Senior Vice President, Corporate Development90% 適合

Proven track record of driving inorganic growth and strategic partnerships across genomics, diagnostics, and biopharma. Experience aligns with SVP-level ownership of global BD and strategy.

3

Vice President / Head of Corporate Strategy & Development88% 適合

Deep experience in strategy development, portfolio planning, and partner management; fits a high-level role focusing on long-range strategic planning and deal execution.

4

Global Head of Strategic Partnerships & Alliances83% 適合

Strong history managing global NGO partnerships and cross-functional alliances; suitable for a role overseeing multi-regional partnerships and external collaborations.

5

Senior Director / Vice President, Business Development & Licensing (Rare Diseases)78% 適合

Rare diseases expertise and BD/ Licensing focus align with growth-stage biotech needs; well-suited for leading licensing initiatives and external collaborations in a disease-focused company.

AI Recruiterを体験する

無料で始めましょう。ライバルに先を越されないでください。

AI駆動の採用ソリューションを活用して、採用プロセスを自動化し、時間コストの80%を削減している10,000社以上の企業に加わりましょう。

33%オフ、残り48時間のみ!
AIを無料で試す

24時間365日自動運用

AIを活用した候補者スクリーニング

地理的・時差の制限なく採用活動

パーソナライズされたインテリジェントコミュニケーション

候補者エンゲージメントの自動評価

あなたの採用スタイルをインテリジェントに模倣・再現

4ヶ月間の返金保証

LinkedInアカウントのセキュリティを確保